Fetal bovine serum atlanta biologicals INC:1109260 [17-004811]
Ended Awarded
- Contract number
- HHSN26400001
- Awardee
-
Atlanta Biologicals, Inc. UEI ULFTKRGFBBA5
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,200
Award facts
- Contract value 100% obligated
- $17,199.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Flowery Branch, GA, USA
Award details come from SAM.gov/FPDS.
About this award
Atlanta Biologicals, Inc. was awarded a contract by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) for the supply of fetal bovine serum, a critical reagent used in biomedical research and cell culture applications. Executed as a Blanket Purchase Agreement (BPA) call on August 23, 2017, this firm fixed-price contract carried a ceiling value of $17,199.56 and was completed by November 30, 2017. The contract was performed at the awardee's facility in Flowery Branch, Georgia, with no set-aside designation applied.
This procurement supported NIAMSD's research mission within the National Institutes of Health, which focuses on disorders affecting bones, joints, muscles, and skin. Fetal bovine serum is an essential component in laboratory settings for cell culture media supplementation, enabling researchers across NIAMSD's portfolio to conduct studies on arthritis, musculoskeletal diseases, and dermatological conditions. As a BPA call against an existing agreement, this award represents a task order drawdown for specific quantities of the biological reagent required by the agency's research programs.
Quick answers
Who was awarded contract HHSN26400001?
HHSN26400001 was awarded to Atlanta Biologicals, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 23, 2017.
How much is contract HHSN26400001 worth?
The government has obligated $17,200 on HHSN26400001.
Is contract HHSN26400001 an order under another contract?
Yes. HHSN26400001 is a BPA call under HHSN263201600020B, a blanket purchase agreement.
Was contract HHSN26400001 competed?
The extent of competition for HHSN26400001 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award